REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.

Related Keywords

Japan ,Hawaii ,United States ,Brazil ,Israel ,Hawaiian ,America ,American ,Steve Pakola ,Dane Leone ,Andreas Argyrides ,Lisa Walter ,Mani Foroohar ,Patrick Christmas ,Alec Stranahan ,Caroline Palomeque ,Brian Skorney ,Ellie Merle ,Gena Wang ,University Of Pennsylvania ,Morgan Stanley ,American Academy Of Ophthalmology Meeting ,Regenxbio Inc ,Pfizer ,American Academy Of Ophthalmology ,Nasdaq ,World Muscle Society Congress ,Society For The Study ,Exchange Commission ,World Muscle Society ,Rockville Manufacturing Innovation Center ,Express ,Barclays ,Call Transcript August ,Chief Legal ,Ken Mills ,Chief Medical Officer ,Vit Vasista ,Chief Financial Officer ,Investor Day ,Fellow Eye ,Hawaiian Eye ,American Academy ,Ophthalmology Meeting ,Annual Symposium ,Eye Care ,Inborn Errors Of Metabolism ,Microdystrophin Expression ,Western Blot Assays ,Unidentified Analyst ,Danon Disease ,Sarepta Advisory ,Vikram Pure ,World Muscle ,Luca Issi ,Lorena Song ,Berenberg Capital ,